Tempus Growth, Revenue, Number of Employees and Funding
Estimated Revenue & Financials
- Tempus received $110.0M in venture funding in August 2018. 0
- Tempus's total funding is $260M.
- Tempus has 656 Employees.
- Tempus grew their employee count by 62% last year.
- Tempus currently has 55 job openings.
|Amy Gordon Franzen||Senior Director Of Operations|
|Britt Oergel||Vice President, East Coast|
|Laura Elster||Vice President, US Sales|
|Jennifer Clauson||Clinical Research Operations Director|
|Matt Love||Vice President, Business Development|
|Robert Tell||Sr Director, Bioinformatics|
|Jeff Schaeffer||Senior Director, Product Management|
|Jim Rogers||Senior Director of Finance|
|Ryan Fukushima||Chief Operating Officer|
|Eric Singley||Vice President of Product|
What Is Tempus?
Tempus is a technology company that is building the worldâ€™s largest library of molecular and clinical data and an operating system to make that data accessible and useful. We enable physicians to deliver personalized cancer care for patients through our interactive analytical and machine learning platform. We provide genomic sequencing services and analyze molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data. For more information, visit tempus.com and visit us on Facebook (Tempus Labs) and Twitter (@TempusLabs). For more information on Eric Lefkofsky, visit lefkofsky.com.keywords:N/A
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|Heidolph North ...||$5.7M||51||16%|
Genmab and Tempus sign agreement to research and develop ... that it has entered into a strategic collaboration agreement with Tempus, ...
CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and ...
Tempus, a Chicago-based biotech startup building a massive library of clinical and molecular data and an accompanying machine ...
|2017-09-26||$70.0M||C||New Enterprise Associates||Article|
|2018-03-21||$80.0M||Undisclosed||T. Rowe Price||Article|
Tempus Executive Hires
|2017-04-06||Erik Phelps||VP General Counsel||Article|